HLA — Healthia Share Price
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- AU$251.64m
- AU$452.22m
- AU$252.56m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 15.69 | ||
| PEG Ratio (f) | 0.79 | ||
| EPS Growth (f) | 24.86% | ||
| Dividend Yield (f) | 1.11% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.64 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 16.74 | ||
| Price to Sales | 1 | ||
| EV to EBITDA | 9.52 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.57% | ||
| Return on Equity | 3.78% | ||
| Operating Margin | 8.93% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 65.08 | 87.22 | 136.95 | 200.26 | 252.56 | 281.8 | 294.8 | 49.06% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +3251.76 | n/a | n/a | -71.85 | +744.41 | +42.84 | +9.09 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Healthia Limited is an integrated allied healthcare company, which includes networks of optometry, podiatry, and physiotherapy clinics. The Company’s segments include Feet and Ankles Division, Bodies and Minds Division, and Eyes and Ears Division. The Ankles Division provides podiatry services and podiatry-related services, including the manufacturing and sale of orthotics and podiatry-related products. The Bodies and Minds Division provides physiotherapy and specialty hand therapy services. The Eyes and Ears Division provides optometry and audiology services. Its podiatry services include foot care services and treatments including but not limited to custom foot orthotics, fungal nail laser treatment, video gait analysis, shockwave therapy, and cryotherapy. Its physiotherapy services consist of injury management and rehabilitation that enable them to deliver treatments for all sporting and non-sporting conditions, injuries, chronic conditions and post-operative rehabilitation.
Directors
- Glen Richards NEC
- Wesley Coote CEO
- Christopher Banks CFO
- Katherine Baker COO
- Lisa Roach CHO
- Dean Hartley CTO
- Anthony Ganter EDR
- Colin Kangisser EDR
- Darren Stewart EDR
- Lisa Dalton NID
- Paul Wilson NID
- Last Annual
- June 30th, 2023
- Last Interim
- June 30th, 2023
- Incorporated
- May 10th, 2018
- Public Since
- September 11th, 2018
- No. of Shareholders
- 2,440
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 140,192,000
- Address
- L4 East Tower, 25 Montpelier Road, BOWEN HILLS, 4006
- Web
- https://www.healthia.com.au/
- Phone
- +61 731804900
- Contact
- Alfred Chan
- Auditors
- BDO Audit Pty Ltd
Upcoming Events for HLA
Half Year 2024 Healthia Ltd Earnings Release
Similar to HLA
Apiam Animal Health
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
Capitol Health
Australian Stock Exchange - SEATS
FAQ
What is the Healthia share price?
As of Today at 18:11 UTC, shares in Healthia are trading at AU$1.80. This share price information is delayed by 15 minutes.
How has the Healthia share price performed this year?
Shares in Healthia last closed at AU$1.80 and the price had moved by +52.77% over the past 365 days. In terms of relative price strength the Healthia share price has outperformed the ASX All Ordinaries Index by +52.45% over the past year.
What are the analyst and broker recommendations for Healthia?
The overall consensus recommendation for Healthia is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Healthia dividend yield?
Healthia does not currently pay a dividend.
Does Healthia pay a dividend?
Healthia does not currently pay a dividend.
When does Healthia next pay dividends?
Healthia does not currently pay a dividend.
How do I buy Healthia shares?
To buy shares in Healthia you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Healthia?
As of the previous close price of AU$1.80, shares in Healthia had a market capitalisation of AU$251.64m.
Where are Healthia shares listed?
Here are the trading details for Healthia:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: HLA
What kind of share is Healthia?
Based on an overall assessment of its quality, value and momentum Healthia is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Healthia share price forecast for 2023?
The analyst consensus target price for shares in Healthia is AU$1.80. That is 0.28% above the last closing price of AU$1.80.
Analysts covering Healthia currently have a consensus Earnings Per Share (EPS) forecast of AU$0.11 for the next financial year.
What is the trend in the Healthia share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Healthia. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +53.58%.
As of the last closing price of AU$1.80, shares in Healthia were trading +32.98% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Healthia PE Ratio?
The Healthia PE ratio based on its reported earnings over the past 12 months is 15.69. The shares last closed at AU$1.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Healthia?
Healthia's management team is headed by:
- Glen Richards - NEC
- Wesley Coote - CEO
- Christopher Banks - CFO
- Katherine Baker - COO
- Lisa Roach - CHO
- Dean Hartley - CTO
- Anthony Ganter - EDR
- Colin Kangisser - EDR
- Darren Stewart - EDR
- Lisa Dalton - NID
- Paul Wilson - NID